Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Citi
Merck
Teva
Medtronic
Federal Trade Commission
Fish and Richardson
Mallinckrodt
Cantor Fitzgerald

Generated: January 21, 2018

DrugPatentWatch Database Preview

HYDROMORPHONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Hydromorphone Hydrochloride patents expire, and what generic alternatives are available?

Hydromorphone Hydrochloride is a drug marketed by Akorn, Barr, Hospira, Hospira Inc, Watson Labs, Ascent Pharms Inc, West-ward Pharms Int, Actavis Labs Fl Inc, Osmotica, Paddock Llc, Aurolife Pharma Llc, Elite Labs, Lannett, Mallinckrodt, and Nesher Pharms. and is included in nineteen NDAs.

The generic ingredient in HYDROMORPHONE HYDROCHLORIDE is hydromorphone hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
Drug patent expirations by year for HYDROMORPHONE HYDROCHLORIDE
Pharmacology for HYDROMORPHONE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for HYDROMORPHONE HYDROCHLORIDE

US Patents and Regulatory Information for HYDROMORPHONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 077471-001 Dec 9, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 077471-002 Dec 9, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mallinckrodt HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 076855-002 Sep 19, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 078439-001 Dec 9, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride INJECTABLE;INJECTION 078228-001 Apr 14, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Osmotica HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 205629-003 Jul 7, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 205814-001 May 13, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 074597-003 May 29, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride INJECTABLE;INJECTION 200403-003 Dec 1, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nesher Pharms HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 077311-001 Nov 9, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
McKinsey
Moodys
Julphar
Argus Health
Chinese Patent Office
US Army
Chubb
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot